Found 732 results for pharmaceutical-industry

7 Corporate Gifting Opportunities for Pharmaceutical Companies

December 18, 2023 by David Parry

It’s no wonder that there are abundant opportunities for corporate gifting for pharma companies....

 Blog Post

Roche Pharmaceutical Industry Deal Gift

Custom tombstone marking Roche’s acquisition of Constitution Medical Inc. Headquartered in Boston, CMI is a developer of laboratory products

1 Image

Pharmaceutical Industry Milestone Commemorative

Lucite commemorative celebrating the first anniversary of FDA approval of Imbruvica. Imbruvica is an inhibitor used in the treatment of three different kinds of blood cancers.

1 Image

Pharmaceutical Industry Deal Toy

1 Image

Oasmia Pharmaceutical Lucite Tombstone

Lab beaker-themed deal toy commemorating a private placement of shares in Oasmia Pharmaceutical. Based in Uppsala, Sweden, Oasmia specializes in drug development in human and veterinary oncology.

1 Image

Flag-Themed Pharmaceutical Deal Toy

Custom crystal deal toy commemorating the acquisition of Canada’s Dalton Pharma Services by Japanese pharmaceutical firm Seikagaku Corporation.

(20AMF085)
2 Images
Crystal deal toy marking a cross-border acquisition of Canadian Dalton Pharma Services. The acquirer was Seikagaku Corporation, an R&D-centered Japanese pharmaceutical firm.

Crystal Commemorative for Pharmaceutical Launch

Custom crystal commemorative celebrating the launch of Wynzora Cream, a topical treatment for plaque psoriasis that received approval from the FDA (Food and Drug Administration) in 2020. The product launch resulted from a collaboration agreement between Denmark-based MC2 Therapeutics, and EPI Health, a specialty pharmaceutical firm headquartered in Charleston, South Carolina.

(21ADH022)
1 Image

Pill-Themed Pharmaceutical Deal Tombstone

Pill-themed tombstone commemorating two transactions in the Australian pharmaceutical sector.

(5SSC765)
1 Image

Commemorative for Pharmaceutical Collaboration

Lucite commemorative marking the research, development, and commercialization  agreement between Sanofi and Regenereon. The pharmaceutical firms will focus on antibody cancer treatment s in the field of immuno-oncology.

(5ALR849)
1 Image